Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Impact of the COVID-19 Pandemic on the Incidence Registry of Hematological Neoplasms in the Region of Madrid (Spain). Preliminary Report of 2014-2021

Blood (2022) 140 (Supplement 1): 10965–10966.

https://doi.org/10.1182/blood-2022-167155

Published: 2022

Journal Articles

Compassionate Use of Belantamab Mafodotin for Treatment of Patients with Relapsed/Refractory Multiple Myeloma Heavily Treated. Spanish Experience

Blood (2021) 138 (Supplement 1): 3775.

https://doi.org/10.1182/blood-2021-151267

Published: 2021

Journal Articles

COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)

Per Ljungman, MD PhD, Rafael De La Camara, MD, Malgorzata Mikulska, Gloria Tridello, Beatriz Aguado, MD, Yves Beguin, MD PhD, Rodrigo Martino Bufarull, Fabio Ciceri, MD, Lucía López Corral, MD, Claudia Crippa, MD, Dries Deeren, MD PhD, Rafael F. Duarte, MD PhD FRCP, María Laura Fox, Anna Grassi, MD, María-José Jimenez, MD, Safiye Koculu, MD, Mi Kwon, MD PhD, Juan Carlos Vallejo Llamas, Jose Luiz Lopez Lorenzo, MD, Stephan Mielke, MD, Javier López Jiménez, MD PhD, Zoraida Mesa Morales, Kim H. Orchard, MBBS,PhDFRCP,FRCPath, Rocio Parody Porras, Victoria Potter, MBBS, BSc, FRACP, FRCPA, María Suárez-Lledó, MD, Nicolaas Schaap, MD PhD, Celestine Simand, MD, Luisa Sisinni, MD, John A Snowden, MD PhD, Daniele Vallisa, MD, Ipek Yonalhindilerden, Alienor Xhaard, MD, Nina Simone Knelange, Angel Cedillo, Nicolaus Kröger, MD, Jose Luis Piñana Sanchez, Jan Styczynski, MD PhD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-138732

Published: 2020

Journal Articles

Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group

Rebeca Bailén, MD, Mi Kwon, MD PhD, Beatriz Aguado, MD, Rafael F. Duarte, MD PhD FRCP, Maria Calbacho, MD, Anabelle Chinea, MD, Pilar Llamas, MDPhD, Rosalía Riaza Grau, Jose Angel Hernandez-Rivas, MD PhD, Victor Jimenez Yuste, MD PhD, Carmen Martínez-Chamorro, MD, F. Javier Penalver, MD, Ataulfo González, MD, Juan F del Campo, Keina Quiroz, MD, Gillen Oarbeascoa, MD, Julio Garcia Suarez, José Luis Díez-Martín, MD PhD

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-138728

Published: 2020

Journal Articles

Dynamics of Hemorragic Events and Primary Hemostasis Deffects during Treatment with Ibrutinib. Real-Life Experience

Natalia Acedo, Javier Loscertales, Beatriz Aguado, MD, Yizel Paz, Elena Jimenez-Barral, Alvaro Arriero, Adrian Alegre

Blood (2016) 128 (22): 4936.

https://doi.org/10.1182/blood.V128.22.4936.4936

Published: 2016

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplant in Advanced Multiple Myeloma: Experience from a Single Center

Yizel Elena Paz Nuñez, Beatriz Aguado Bueno, Isabel vicuña Andrés, Ángela Figuera Álvarez, Miriam González-Pardo, Rafael de la Cámara Llanzá, Valle Gómez García de Soria, Reyes Arranz Sáez, MD, Alvaro Arriero García, Elena Jiménez Barral, Susie Veramendi Zavala, Adrian Alegre

Blood (2015) 126 (23): 5536.

https://doi.org/10.1182/blood.V126.23.5536.5536

Published: 2015

Journal Articles

Peripheral T/NK-Cell Lymphomas: Survival with Current Treatment Strategies. La Princesa University Hospital Single Experience

Miriam González-Pardo, Carlos Fernández-Arandojo, Jimena Cannata, Beatriz Aguado, Ana García-Noblejas, MD, Adrian Alegre, Reyes Arranz, MD PhD

Blood (2014) 124 (21): 5897.

https://doi.org/10.1182/blood.V124.21.5897.5897

Published: 2014

Journal Articles

Comparison of Assesment of Imaging Response with Magnetic Resonance (MR) and 18 fdg-PET/TC in Multiple Myeloma (MM). Single Centre Experience

Adrian Alegre, Beatriz Aguado, Miriam González-Pardo, Evelyn Acuña, Álvaro Arriero, Maria Aragonés, Lourdes Del Campo, S Llorente, Elena Ocón, Nieves Gómez León

Blood (2014) 124 (21): 5707.

https://doi.org/10.1182/blood.V124.21.5707.5707

Published: 2014

Journal Articles

Preliminary Experience of the Spanish Compassionate Use Registry of Bendamustine in Patients with Relapsed and/or Refractory Multiple Myeloma

Beatriz Aguado Bueno, Isabel VicuÑa Andres, Laura Entrena, Felipe De Arriba, Isabel Krisnik, BegoÑa Navas, Marta Callejas, Anabel Teruel, Aurelio Lopez, Tomas Gonzalez Lopez, Inmaculada Castillo, Jaime Perez De Oteyza, Dunia De Miguel, Sara Rivas Calvo, Raquel Rodriguez Posada, Adrian Alegre

Blood (2012) 120 (21): 4035.

https://doi.org/10.1182/blood.V120.21.4035.4035

Published: 2012

Journal Articles

Personalized Treatment with low doses of Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma in frail or Elderly Patients

Angel Ruedas, MD, Pablo Guisado, MD, PhD, Beatriz Aguado, MD, PhD, Ricardo Perez, MD, Joaquin Martinez, MD, J Valentin Garcia-Gutierrez, MD, PhD, M. Jesús Blanchard, MD, Pilar Bravo, MD, Carlos Montalban

Blood (2012) 120 (21): 5049.

https://doi.org/10.1182/blood.V120.21.5049.5049

Published: 2012

Journal Articles

Laser Transmyocardial Revascularization (TMLR) Combined with Autologous Bone Marrow Cells (ABMC) for Diffuse Coronary Disease (DCD). Results In 19 Cases

Adrian Alegre, Beatriz Aguado, Hematology, Ph, M. Perez Alfonso, Inmunology, C. Muñoz, Inmunology, M. Ortiz de Landázuri, Inmunology, F. Madrid Sanchez, Inmunology, C. Cámara, Hematology, N. García-Fernández, Hematology, Data, Manager, L. Bascones, Hematology, S. Martinez, Hematology, N. García-León, Hematology, M. Roig, Hematology, J. Duarte, Cardivascular, G. Reyes, Cardivascular

Blood (2010) 116 (21): 1181.

https://doi.org/10.1182/blood.V116.21.1181.1181

Published: 2010

NARROW

Impact of the COVID-19 Pandemic on the Incidence Registry of Hematological Neoplasms in the Region of Madrid (Spain). Preliminary Report of 2014-2021

Compassionate Use of Belantamab Mafodotin for Treatment of Patients with Relapsed/Refractory Multiple Myeloma Heavily Treated. Spanish Experience

COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)

Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group

Dynamics of Hemorragic Events and Primary Hemostasis Deffects during Treatment with Ibrutinib. Real-Life Experience

Allogeneic Hematopoietic Stem Cell Transplant in Advanced Multiple Myeloma: Experience from a Single Center

Peripheral T/NK-Cell Lymphomas: Survival with Current Treatment Strategies. La Princesa University Hospital Single Experience

Comparison of Assesment of Imaging Response with Magnetic Resonance (MR) and 18 fdg-PET/TC in Multiple Myeloma (MM). Single Centre Experience

Preliminary Experience of the Spanish Compassionate Use Registry of Bendamustine in Patients with Relapsed and/or Refractory Multiple Myeloma

Personalized Treatment with low doses of Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma in frail or Elderly Patients

Laser Transmyocardial Revascularization (TMLR) Combined with Autologous Bone Marrow Cells (ABMC) for Diffuse Coronary Disease (DCD). Results In 19 Cases

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only